September is World Alzheimer’s month.

Let’s spread awareness together!

Alzheimer’s Disease (AD) is the most wide-spread form of dementia affecting dozens of millions patients worldwide. This is a condition that impacts both the quality of life of the suffering individual and their friends and family. While no cure is currently available, there is a growing number of facilities and treatment options to mitigate the disease and to offer much-needed support to families. Clinical trials are also ongoing worldwide in the search for the cure for Alzheimer’s Disease.

GCT focuses on CNS and Neurology trials and has been running trials in Alzheimer’s Disease since 2001. We are closely familiar with Key Opinion Leaders (KOLs) and the best clinical sites worldwide. Reach out to GCT at for more information.